CME

Upon completion of the educational activity, participants should be able to:

• Review current treatment options for patients with alopecia areata including recent JAK inhibitors
• Compare new and emerging therapies for Atopic Dermatitis (AD)
• Compare and contrast established and novel therapies for treatment of acne
• Review treatment options for current and emerging therapies for the treatment of actinic keratosis 
• Discuss advances in treatment of non-melanoma skin carcinomas including rare skin tumors
• Review new and emerging treatments for basal cell carcinoma and squamous cell carcinoma
• Discuss application for various neurotoxins, dermal fillers, surgical and minimally invasive treatments for facial rejuvenation and elimination of submental fat
• Compare and contrast available options for non‐invasive body contouring and reduction of cellulite with energy-based devices 
• Recognize strategies and treatments for a diverse patient population including ethnic and gender differences
• Discuss indications, contraindications, and properties of existing and emerging neuromodulators and dermal fillers approved for use in the US
• Review the anatomy and injection techniques for specific regions of the face including the chin, jawline and brow
• Discuss treatment options for molluscum contagiosum
• Review the prevalence, severity, and impact of primary axillary hyperhidrosis and other common forms of hyperhidrosis
• Review the prevalence, severity, and impact of hidradenitis suppurativa (HS)
• Review treatment options for patients with hair loss
• Review the latest advanced techniques in lasers, light, ultrasound, and radiofrequency devices
• Identify the current and emerging therapies available to manage moderate to severe psoriasis
• Review treatment strategies, based on knowledge of the indications, efficacy, and risks of available rosacea therapies, to achieve therapeutic goals in rosacea treatment
• Describe advances in the management of patients with vitiligo

There is a  fee to participate in this activity. Statements of credit will be awarded based on the participant’s attendance.  A statement of credit will be available upon completion of an online evaluation/claim credit form available at: 

CE credit provided by AKH Inc., Advancing Knowledge in Healthcare.

In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and Compass. AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

This activity was planned by and for the healthcare team, and learners will receive 24 Interprofessional Continuing Education (IPCE) credit for learning and change.

AKH Inc., Advancing Knowledge in Healthcare designates this live activity for a maximum of 24 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Credit being awarded: 24 ANCC contact hours

AKH Inc., Advancing Knowledge in Healthcare has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 24 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

This activity is supported by educational grants from AbbVie Inc., Almirall, LLC, Bausch Health US, LLC, Evolus, Sun Pharmaceutical Industries, Inc., Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC.

This activity is supported from in-kind support from AbbVie Inc., Evolus, Galderma Laboratories, L.P., Merz North America, Inc., Revance.

It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by AKH prior to accreditation of the activity. AKH planners and reviewers have no relevant financial relationships to disclose.

This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participants misunderstanding of the content.

Upon completion of the educational activity, participants should be able to:

• Review the latest advanced techniques for energy-based devices to provide optimum patient outcomes and reduce complications.
• Describe laser physics and laser safety.
• Compare and contrast the various types of lasers.

CE credit provided by AKH Inc., Advancing Knowledge in Healthcare. 

In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and SCALE. AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

AKH Inc., Advancing Knowledge in Healthcare designates this live activity for a maximum of 6.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Credit being awarded: 6.5 ANCC contact hours

AKH Inc., Advancing Knowledge in Healthcare has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 6.5 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by AKH prior to accreditation of the activity. AKH planners and reviewers have no relevant financial relationships to disclose.

This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participants misunderstanding of the content.

Upon completion of the educational activity, participants should be able to:

• Describe the anatomy of the face in terms of volume loss and structural changes in multiple tissue layers
• Identify the functional aspect of facial muscles including surface landmarks
• Assess a patient’s candidacy for facial rejuvenation with neurotoxin, dermal fillers and deoxycholic acid
• Recognize the appropriate anatomical plane for injection when using dermal fillers and deoxycholic acid
• Differentiate among dermal filler agents
• Distinguish between sensory and nerve anatomy
• Perform neurotoxin, dermal filler and deoxycholic acid injections for a range of indications
• Identify anatomical ‘danger zones’ which may result in adverse events or permanent injury if neurotoxin, dermal fillers or deoxycholic acid are injected improperly
• Assess the benefits of utilizing ultrasound technology for guided anatomy mapping and injections

CE credit provided by AKH Inc., Advancing Knowledge in Healthcare. 

In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and SCALE. AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

AKH Inc., Advancing Knowledge in Healthcare designates this live activity for a maximum of 6 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Credit being awarded: 6 ANCC contact hours

AKH Inc., Advancing Knowledge in Healthcare has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 6 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by AKH prior to accreditation of the activity. AKH planners and reviewers have no relevant financial relationships to disclose.

This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participant’s misunderstanding of the content.

Upon completion of the educational activity, participants should be able to:

• Assess the benefits of utilizing ultrasound technology for guided anatomy mapping and injections to prevent complications.
• Review how to perform an Ultrasound examination of the face and injecting and identifying fillers under Ultrasound guidance.

CE credit provided by AKH Inc., Advancing Knowledge in Healthcare. 

In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and SCALE. AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

AKH Inc., Advancing Knowledge in Healthcare designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Credit being awarded: 1.5 ANCC contact hours

AKH Inc., Advancing Knowledge in Healthcare has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.5 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by AKH prior to accreditation of the activity. AKH planners and reviewers have no relevant financial relationships to disclose.

This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participants misunderstanding of the content.

Upon completion of the educational activity, participants should be able to:

• Review clinical evidence supporting the long-term outcomes of multimodal approaches.
• Identify strategies for minimizing complications and managing adverse events in combination treatments for facial and neck rejuvenation.
• Identify best practices for combining injectables to optimize aesthetic outcomes and patient satisfaction.

There is a fee to participate in this activity. Statements of credit will be awarded based on the participant’s attendance.  A statement of credit will be available upon completion of an online evaluation/claim credit form.

CE credit provided by AKH Inc., Advancing Knowledge in Healthcare. 

In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and Compass. AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

AKH Inc., Advancing Knowledge in Healthcare designates this live activity for a maximum of 3 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Credit being awarded: 3 ANCC contact hours

AKH Inc., Advancing Knowledge in Healthcare has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 3 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by AKH prior to accreditation of the activity. AKH planners and reviewers have no relevant financial relationships to disclose.

This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participants misunderstanding of the content. If you would like to opt out from future communications from AKH please send an email to optout@akhcme.com with your information with “Opt Out” in the subject line.